Sarepta Therapeutics | Eiendeler

Assets Endring Dato
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Avrobio USD 92.35M 8.74M 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Daiichi Sankyo JPY 3.27T 619.84B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Incyte USD 7.14B 353.5M 2024-03
Insmed USD 1.16B 170.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Moderna USD 16.73B 1.7B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Sarepta Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.